DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia

Overview of attention for article published in Cancer Cell, January 2010

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news: 2 news outlets
blogs: 1 blog
twitter: 2 X users
patent: 8 patents

facebook: 1 Facebook page
f1000: 1 research highlight platform
q&a: 1 Q&A thread

Readers on

mendeley: 652 Mendeley
citeulike: 4 CiteULike

So far, Altmetric has seen 8 patents that reference this research output.

MULTIFUNCTIONAL NATURAL KILLER (NK) CELL ENGAGER COMBINATION THERAPY FOR TREATING…

Application WO-2025114919-A1

World Intellectual Property Organisation (WIPO)

05 Jun 2025

Hypomethylation of TET2 target genes for identifying a curable subgroup of acute myeloid…

Grant US-12018330-B2

United States of America

25 Jun 2024

Methods for detecting genomic DNA methylation

Grant US-11473131-B2

United States of America

18 Oct 2022

METHOD OF TREATMENT AND PRONOSTIC OF ACUTE MYELOID LEUKEMIA

Application WO-2021044012-A1

World Intellectual Property Organisation (WIPO)

11 Mar 2021

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 4 additional patents.